Cas:329722-47-6 chloro-(3,6-ditert-butyl-9H-fluoren-9-yl)-dimethylsilane manufacturer & supplier

We serve Chemical Name:chloro-(3,6-ditert-butyl-9H-fluoren-9-yl)-dimethylsilane CAS:329722-47-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

chloro-(3,6-ditert-butyl-9H-fluoren-9-yl)-dimethylsilane

Chemical Name:chloro-(3,6-ditert-butyl-9H-fluoren-9-yl)-dimethylsilane
CAS.NO:329722-47-6
Synonyms:chloro-(3,6-ditert-butyl-9H-fluoren-9-yl)-dimethylsilane
Molecular Formula:C23H31ClSi
Molecular Weight:371.03100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:449.8ºC at 760mmHg
Density:1.03g/cm3
Index of Refraction:1.55
PSA:
Exact Mass:370.18800
LogP:7.47250

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like chloro-(3,6-ditert-butyl-9H-fluoren-9-yl)-dimethylsilane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,chloro-(3,6-ditert-butyl-9H-fluoren-9-yl)-dimethylsilane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,chloro-(3,6-ditert-butyl-9H-fluoren-9-yl)-dimethylsilane Use and application,chloro-(3,6-ditert-butyl-9H-fluoren-9-yl)-dimethylsilane technical grade,usp/ep/jp grade.


Related News: As further tools are created to improve biocatalyst development, these can likewise be assessed for their capacity to add value to a project. 1,2,3,4-oxatriazol-5-amine hydrochloride manufacturers Grégoire then joined telecoms service provider Cirpack, following its acquisition of Andrexen, as Chief Marketing and Product Officer. He most recently held the position of Chief Strategy Officer at Experty.io, a blockchain-based knowledge sharing platform. 1-[6-fluoro-(2R)-3,4-dihydro-2H-1-benzopyran-4-one]-(1S)-1,2-ethylene glycol suppliers Joan Merrill, Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Research Program, US, said: “Arthritis and rash are the most common and persistent problems in lupus and often have a significant impact on a person’s life. The strength of the data from this analysis is that anifrolumab was found to be consistently effective using three different ways of looking at rash and three different approaches to arthritis. N’-(2-(4-(3,3-diphenylpropyl)-1,4-diazepan-1-yl)acetyl)-4-nitrobenzohydrazide vendor & factory.